A recommendation for the use of electrical biosensing technology in neonatology.

Autor: van Wyk L; Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa. lizelle@sun.ac.za., Austin T; Neonatal Intensive Care Unit, Rosie Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK., Barzilay B; Neonatal Intensive Care Unit, Assaf Harofeh Medical Center, Tzrifin, Israel., Bravo MC; Department of Neonatology, La Paz University Hospital and IdiPaz, Madrid, Spain., Breindahl M; Department of Neonatology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Czernik C; Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Dempsey E; Department of Paediatrics and Child Health, University College Cork, Cork, Ireland., de Boode WP; Department of Neonatology, Radboud University Medical Center, Radboud Institute for Health Sciences, Amalia Children's Hospital, Nijmegen, The Netherlands., de Vries W; Division of Woman and Baby, Department of Neonatology, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht University, Utrecht, The Netherlands., Eriksen BH; Department of Paediatrics, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Clinical Research Unit, Norwegian University of Science and Technology, Trondheim, Norway., Fauchére JC; Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kooi EMW; Division of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University of Groningen, University Medical Centre, Groningen, The Netherlands., Levy PT; Department of Newborn Medicine, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., McNamara PJ; Department of Paediatrics, University of Iowa, Iowa City, IA, USA., Mitra S; Institute for Women's Health, University College London, London, UK., Nestaas E; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Clinic of Paediatrics and Adolescence, Akershus University Hospital, Lørenskog, Norway., Rabe H; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Rabi Y; University of Calgary, Alberta, Canada., Rogerson SR; Newborn Research Centre, The Royal Women's Hospital, Melbourne, VIC, Australia.; Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, VIC, Australia., Savoia M; Neonatal Intensive Care Unit, S Maria Della Misericordia Hospital, Udine, Italy., Schena F; Ospedale Maggiore Policlinico, Milano, Italy., Sehgal A; Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia.; Department of Paediatrics, Monash University, Melbourne, VIC, Australia., Schwarz CE; Department of Neonatology, Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany., Thome U; Division of Neonatology, Department of Pediatrics, University of Leipzig Medical Centre, Leipzig, Germany., van Laere D; Neonatal Intensive Care Unit, Universitair Ziekenhuis, Antwerp, Belgium., Zaharie GC; Neonatology Department, University of Medicine and Pharmacy, Iuliu Hatieganu, Cluj -Napoca, Romania., Gupta S; Department of Engineering, Durham University, Durham, UK.; Division of Neonatology, Department of Pediatrics, Sidra Medicine, Doha, Qatar.
Jazyk: angličtina
Zdroj: Pediatric research [Pediatr Res] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
DOI: 10.1038/s41390-024-03369-z
Abstrakt: Non-invasive cardiac output monitoring, via electrical biosensing technology (EBT), provides continuous, multi-parameter hemodynamic variable monitoring which may allow for timely identification of hemodynamic instability in some neonates, providing an opportunity for early intervention that may improve neonatal outcomes. EBT encompasses thoracic (TEBT) and whole body (WBEBT) methods. Despite the lack of relative accuracy of these technologies, as compared to transthoracic echocardiography, the use of these technologies in neonatology, both in the research and clinical arena, have increased dramatically over the last 30 years. The European Society of Pediatric Research Special Interest Group in Non-Invasive Cardiac Output Monitoring, a group of experienced neonatologists in the field of EBT, deemed it appropriate to provide recommendations for the use of TEBT and WBEBT in the field of neonatology. Although TEBT is not an accurate determinant of cardiac output or stroke volume, it may be useful for monitoring longitudinal changes of hemodynamic parameters. Few recommendations can be made for the use of TEBT in common neonatal clinical conditions. It is recommended not to use WBEBT to monitor cardiac output. The differences in technologies, study methodologies and data reporting should be addressed in ongoing research prior to introducing EBT into routine practice. IMPACT STATEMENT: TEBT is not recommended as an accurate determinant of cardiac output (CO) (or stroke volume (SV)). TEBT may be useful for monitoring longitudinal changes from baseline of hemodynamic parameters on an individual patient basis. TEBT-derived thoracic fluid content (TFC) longitudinal changes from baseline may be useful in monitoring progress in respiratory disorders and circulatory conditions affecting intrathoracic fluid volume. Currently there is insufficient evidence to make any recommendations regarding the use of WBEBT for CO monitoring in neonates. Further research is required in all areas prior to the implementation of these monitors into routine clinical practice.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: